Peak Bio, Inc. Accretion Expense
Peak Bio, Inc. reported Accretion Expense of $41.25 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-08-18
- Peak Bio, Inc. accretion expense for the quarter ending 2023-06-30 was $41.25K.
- Peak Bio, Inc. accretion expense for the quarter ending 2023-03-31 was $40.80K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month |
|---|---|---|
| 2023-06-30 | $41.25K 10-Q · filed 2023-08-18 | $82.05K derived: sum of 2 quarters · filed 2023-08-18 |
| 2023-03-31 | $40.80K 10-Q · filed 2023-08-18 |